Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma

Introduction: Non-Hodgkin Lymphoma patients respond differently to therapy according to inherent biological variations. Pretherapy biomarkers may improve dose-response prediction. Materials and Methods: Hybrid single-photon emission computed tomography (SPECT)/computed tomography (CT) three-dimensio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Biother Radiopharm
Main Authors: Roberson, Peter L., Smith, Lauren B., Morgan, Meredith A., Schipper, Matthew J., Wilderman, Scott J., Avram, Anca M., Kaminski, Mark S., Dewaraja, Yuni K.
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc. 2017
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5695749/
https://ncbi.nlm.nih.gov/pubmed/29083933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2017.2182
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares